Strides Pharma Science Ltd (BOM:532531) reports robust financial performance with improved margins and successful geographical diversification, despite challenges in the US market.
It is hard to get excited after looking at Victrex's (LON:VCT) recent performance, when its stock has declined 11% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results